Language: BG BG
← Back to results
Recruiting Phase 1 NCT07405177

A Study of MK-7240 in Healthy Participants (MK-7240-009)

Phase 1 – testing safety in a small group of people
Conditions: Healthy

Sponsor: Merck Sharp & Dohme LLC

trial.available_in: БГ
Overview
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
Who can participate
Inclusion Criteria The main inclusion criteria include but are not limited to the following: * Has a body-mass index (BMI) between 18 and 32 kg/m\^2 Exclusion Criteria The main exclusion criteria include but are not limited to the following: * Has a history of more than 1 episode of herpes zoster infection or history of disseminated herpes zoster infection * Has a history of or current active tuberculosis (TB) infection or history of latent TB that was not fully treated
Locations 1
Australia (1)
Nucleus Network ( Site 0002)
Brisbane , Queensland
Study Coordinator
Technical details
Status
Recruiting
Phase
Phase 1
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Maximum age
55 Years
Healthy volunteers
No
Start date
05.03.2026
Completion date
03.09.2026
Registry ID
NCT07405177
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.